Filing status
- Accounts due
- 31 March 2027
- Last accounts
- 30 June 2025
- Conf. stmt due
- 20 June 2027
- Last conf. stmt
- 6 June 2026
Fluorok Limited
- Incorporated
- 7 June 2022 (4 years)
- Previously known as
- Oxfluor Limited (until 15 June 2022)This list may be incomplete. See all names on Companies House
- Industry
- Manufacture of other inorganic basic chemicals (20130) Manufacture of other organic basic chemicals (20140)Manufacture of other chemical products n.e.c. (20590)Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Owned by
- Accounts type
- Total exemption full
- Region
- South East
- Address
- 7400 The QuorumAlec Issigonis WayOxfordOX4 2JZ
Officers
This list may be incomplete. See all officers on Companies House
Officer details are public data from the Companies House register.
Director · Appointed 20 January 2025
British
Born April 1978 (48)
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 20 September 2022
Owns 25–50% of shares
Holds 25–50% of voting rights
Public Limited Company
Reg. no. 09093331
Former controllers (2)
20 September 2022
Ceased Veronique Gouverneur — Owns 25–50% of shares
20 September 2022
Ceased Gabriele Pupo — Owns 25–50% of shares
Group structure 17 shown
Ownership group derived from the Companies House PSC register
Acionna Therapeutics Ltd Owns 50–75% of shares
Animal Dynamics Limited Owns 50–75% of shares
Archangel Lightworks Ltd Owns 25–50% of shares
Ascension Earth Resources Ltd Owns 25–50% of shares
Caudal Energy Limited Owns 25–50% of shares
Caudal Morlais Limited Owns 75–100% of shares
Circadian Therapeutics Limited Owns 75–100% of shares
Cora Biosciences Limited Owns 25–50% of shares
Credo Therapies Ltd Owns 50–75% of shares
Densix Limited Owns 25–50% of shares
Dyna Therapeutics Limited Owns 50–75% of shares
Eligentis Limited Owns 25–50% of shares
Evox Therapeutics Limited Owns 25–50% of shares
Fluorok Limited This company Owns 25–50% of shares
Financials
Balance sheet as at 30 June 2025 · total exemption full accounts
- Net Assets
- £7,206,772
- Cash
- £5,450,354
- Profit
- (£1,797,469)
- Employees
- 15
- Debt Ratio
- 2%
- Current Ratio
- 46.3x
- Return on Equity
- -25%
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Fixed Assets | £1,094,256 | £591,401 | £371,152 |
| Current Assets | £6,247,305 | £1,300,535 | £1,985,477 |
| Cash | £5,450,354 | £926,245 | £1,369,930 |
| Creditors (< 1 year) | £134,789 | £775,342 | £91,189 |
| Net Current Assets | £6,112,516 | £525,193 | £1,894,288 |
| Net Assets | £7,206,772 | £1,116,594 | £2,265,440 |
| Shareholder Funds | £7,206,772 | £1,116,594 | £2,265,440 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 16 September 2026 | Other filing | |||
| 25 August 2026 | Statement of capital following an allotment of shares | |||
| 7 August 2026 | Memorandum and Articles of Association | |||
| 7 August 2026 | Resolutions | |||
| 29 July 2026 | Statement of capital following an allotment of shares |
Other companies in this industry
Bracknell
Chester
West Yorkshire
Aylesbury
Oswaldtwistle
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →